Jong Yeon Hwang

1.4k total citations
68 papers, 1.1k citations indexed

About

Jong Yeon Hwang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jong Yeon Hwang has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 23 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Jong Yeon Hwang's work include Protein Degradation and Inhibitors (10 papers), Cancer therapeutics and mechanisms (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Jong Yeon Hwang is often cited by papers focused on Protein Degradation and Inhibitors (10 papers), Cancer therapeutics and mechanisms (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Jong Yeon Hwang collaborates with scholars based in South Korea, United States and India. Jong Yeon Hwang's co-authors include Young‐Dae Gong, Chi Hoon Park, Jae Du Ha, Chong Ock Lee, Chung Hyo Kang, Duck‐Hyung Lee, R. Kiplin Guy, Fangyi Zhu, Michele Connelly and Sung‐Eun Yoo and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Jong Yeon Hwang

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong Yeon Hwang South Korea 18 577 426 207 101 83 68 1.1k
Suhui Yang South Korea 22 382 0.7× 265 0.6× 93 0.4× 11 0.1× 113 1.4× 41 969
Pan Tang China 19 613 1.1× 58 0.1× 163 0.8× 90 0.9× 42 0.5× 51 1.1k
Alexander V. Kachur United States 17 279 0.5× 96 0.2× 84 0.4× 12 0.1× 203 2.4× 30 1.1k
Kelly Duncan United States 24 566 1.0× 81 0.2× 129 0.6× 144 1.4× 142 1.7× 44 1.2k
Wenhua Jiang China 14 272 0.5× 70 0.2× 71 0.3× 11 0.1× 63 0.8× 48 742
Charles J. R. Hedgecock United Kingdom 18 296 0.5× 253 0.6× 65 0.3× 9 0.1× 174 2.1× 32 1.1k
Ruchi Saxena India 15 203 0.4× 164 0.4× 128 0.6× 86 0.9× 48 0.6× 31 656
Mohammad Askandar Iqbal India 16 988 1.7× 32 0.1× 133 0.6× 10 0.1× 82 1.0× 31 1.3k
Alan Knapton United States 20 364 0.6× 32 0.1× 174 0.8× 53 0.5× 83 1.0× 39 1.1k

Countries citing papers authored by Jong Yeon Hwang

Since Specialization
Citations

This map shows the geographic impact of Jong Yeon Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Yeon Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Yeon Hwang more than expected).

Fields of papers citing papers by Jong Yeon Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Yeon Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Yeon Hwang. The network helps show where Jong Yeon Hwang may publish in the future.

Co-authorship network of co-authors of Jong Yeon Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Yeon Hwang. A scholar is included among the top collaborators of Jong Yeon Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Yeon Hwang. Jong Yeon Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Seulki, et al.. (2025). Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers. Bioorganic & Medicinal Chemistry Letters. 120. 130141–130141. 2 indexed citations
2.
Yu, Nengwei, Ji‐Eun Lee, Seulki Park, et al.. (2024). Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle. Bioorganic & Medicinal Chemistry Letters. 117. 130075–130075. 1 indexed citations
3.
Kim, Seulgi, Yuri Choi, Jin Hwan Kim, et al.. (2022). Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model. Bioorganic Chemistry. 127. 105923–105923. 17 indexed citations
4.
Kang, Chung Hyo, et al.. (2018). Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC). Biochemical and Biophysical Research Communications. 505(2). 542–547. 103 indexed citations
5.
Hwang, Jong Yeon, et al.. (2017). Applications of Hydrochemical Models for the Assessment of Groundwater. 20(3). 156–173. 5 indexed citations
6.
Lee, Joo‐Youn, Ji‐Eun Jeong, Mi‐Ok Kim, et al.. (2017). Synthesis and Molecular Modeling Studies of N′-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors. Molecules. 22(11). 1936–1936. 7 indexed citations
7.
Lee, Chong Ock, et al.. (2017). Novel 2,4-diaminopyrimidines bearing fused tricyclic ring moiety for anaplastic lymphoma kinase (ALK) inhibitor. Bioorganic & Medicinal Chemistry Letters. 27(10). 2185–2191. 11 indexed citations
8.
Kim, Eun Young, Heejung Jung, Chi Hoon Park, et al.. (2016). Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors. Archives of Pharmacal Research. 39(4). 453–464. 11 indexed citations
9.
Raudenský, Miroslav, et al.. (2016). Mutual collision of water jets from adjacent high pressure flat jet nozzles on flat surfaces during hydraulic descaling. Tehnicki vjesnik - Technical Gazette. 23(5). 1 indexed citations
10.
Oh, Sangmi, Jaewon Yang, Eunji Jo, et al.. (2016). Benzothiazepinecarboxamides: Novel hepatitis C virus inhibitors that interfere with viral entry and the generation of infectious virions. Antiviral Research. 129. 39–46. 9 indexed citations
11.
Kang, Chung Hyo, Heung Kyoung Lee, Ha-Yeon Lee, et al.. (2016). Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R. European Journal of Medicinal Chemistry. 126. 536–549. 14 indexed citations
12.
Kang, Chung Hyo, Eun Young Kim, Hyoung Rae Kim, et al.. (2016). Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer. Cancer Letters. 374(2). 272–278. 12 indexed citations
13.
Kang, Chung Hyo, Kwangho Lee, Chong Ock Lee, et al.. (2015). Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins. Biochemical and Biophysical Research Communications. 464(3). 762–767. 4 indexed citations
14.
Park, Chi-Min, Joo Yun Lee, Jae Du Ha, et al.. (2015). Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors. Bioorganic & Medicinal Chemistry. 24(2). 207–219. 11 indexed citations
15.
Kim, Eun‐Young, Heejung Jung, Chi Hoon Park, et al.. (2014). Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(21). 5093–5097. 11 indexed citations
16.
Windisch, Marc P., Soohyun Kim, Keumhyun Kim, et al.. (2014). Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors with a novel mechanism of action. European Journal of Medicinal Chemistry. 78. 35–42. 14 indexed citations
17.
Hwang, Jong Yeon, David C. Smithson, Gloria Holbrook, et al.. (2013). Optimization of the electrophile of chloronitrobenzamide leads active against Trypanosoma brucei. Bioorganic & Medicinal Chemistry Letters. 23(14). 4127–4131. 11 indexed citations
18.
Hwang, Jong Yeon, Wenwei Huang, Leggy A. Arnold, et al.. (2011). Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone. Journal of Biological Chemistry. 286(14). 11895–11908. 31 indexed citations
19.
Hwang, Jong Yeon, et al.. (2009). Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis. Bioorganic & Medicinal Chemistry Letters. 20(1). 149–152. 8 indexed citations
20.
Yu, Soonju, et al.. (1999). Index of Organic Matter in Stream and Lake. Journal of Environmental Impact Assessment. 8(1). 81–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suhui Yang Breakdown of academic impact, for papers by Pan Tang Breakdown of academic impact, for papers by Alexander V. Kachur Breakdown of academic impact, for papers by Kelly Duncan Breakdown of academic impact, for papers by Wenhua Jiang Breakdown of academic impact, for papers by Charles J. R. Hedgecock Breakdown of academic impact, for papers by Ruchi Saxena Breakdown of academic impact, for papers by Mohammad Askandar Iqbal Breakdown of academic impact, for papers by Alan Knapton
Rankless by CCL
2026